Lymphangitis carcinomatosa

WikiDoc Resources for Lymphangitis carcinomatosa
Articles
Most recent articles on Lymphangitis carcinomatosa Most cited articles on Lymphangitis carcinomatosa Review articles on Lymphangitis carcinomatosa Articles on Lymphangitis carcinomatosa in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lymphangitis carcinomatosa Images of Lymphangitis carcinomatosa Photos of Lymphangitis carcinomatosa Podcasts & MP3s on Lymphangitis carcinomatosa Videos on Lymphangitis carcinomatosa
Evidence Based Medicine
Cochrane Collaboration on Lymphangitis carcinomatosa Bandolier on Lymphangitis carcinomatosa TRIP on Lymphangitis carcinomatosa
Clinical Trials
Ongoing Trials on Lymphangitis carcinomatosa at Clinical Trials.gov Trial results on Lymphangitis carcinomatosa Clinical Trials on Lymphangitis carcinomatosa at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lymphangitis carcinomatosa NICE Guidance on Lymphangitis carcinomatosa NHS PRODIGY Guidance FDA on Lymphangitis carcinomatosa CDC on Lymphangitis carcinomatosa
Books
Books on Lymphangitis carcinomatosa
News
Lymphangitis carcinomatosa in the news Be alerted to news on Lymphangitis carcinomatosa News trends on Lymphangitis carcinomatosa
Commentary
Blogs on Lymphangitis carcinomatosa
Definitions
Definitions of Lymphangitis carcinomatosa
Patient Resources / Community
Patient resources on Lymphangitis carcinomatosa Discussion groups on Lymphangitis carcinomatosa Patient Handouts on Lymphangitis carcinomatosa Directions to Hospitals Treating Lymphangitis carcinomatosa Risk calculators and risk factors for Lymphangitis carcinomatosa
Healthcare Provider Resources
Symptoms of Lymphangitis carcinomatosa Causes & Risk Factors for Lymphangitis carcinomatosa Diagnostic studies for Lymphangitis carcinomatosa Treatment of Lymphangitis carcinomatosa
Continuing Medical Education (CME)
CME Programs on Lymphangitis carcinomatosa
International
Lymphangitis carcinomatosa en Espanol Lymphangitis carcinomatosa en Francais
Business
Lymphangitis carcinomatosa in the Marketplace Patents on Lymphangitis carcinomatosa
Experimental / Informatics
List of terms related to Lymphangitis carcinomatosa

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lymphangitis carcinomatosa is inflammation of the lymph vessels secondary to a malignancy. Breast, lung, stomach, pancreas, and prostate cancers are the most common tumors that result in lymphangitis. First described by pathologist Gabriel Andral in 1829 in a patient with uterine cancer.

Related chapters

• Lymphangitis

References

• Bruce DM, Heys SD, Eremin O. (1996). "Lymphangitis carcinomatosa: a literature review". J R Coll Surg Edinb. 41 (1): 7–13. PMID 8930034. CS1 maint: Multiple names: authors list (link)
• Doyle L. (1989). "Gabriel Andral (1797-1876) and the first reports of lymphangitis carcinomatosa". J R Soc Med. 82 (8): 491–3. PMID 2674433. Full text